Literature DB >> 25490145

DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.

Dulanjalee Kariyawasam1, Latif Rachdi, Aurore Carré, Mercè Martin, Marine Houlier, Nathalie Janel, Jean-Maurice Delabar, Raphaël Scharfmann, Michel Polak.   

Abstract

The most common thyroid abnormality among Down syndrome (DS) children corresponds to a mildly elevated TSH, with T4 decreased or in the normal range and thyroid hypoplasia, from the neonatal period onward, which aggravate their mental impairment. Transgenic Dyrk1A mice, obtained by bacterial artificial chromosome engineering (mBACTgDyrk1A), have 3 copies of the Dyrk1A gene. The objective is to determine whether this transgenic Dyrk1A (Dyrk1A(+/++)) mouse is an adequate murine model for the study of thyroid dysgenesis in DS. Embryonic thyroid development from embryonic day 13.5 (E13.5) to E17.5 was analyzed in wild-type (WT) and Dyrk1A(+/++) mice by immunofluorescence with anti-Nkx2-1, anti-thyroglobulin, and anti-T4 antibodies, markers of early thyroid development, hormonogenesis, and final differentiation, respectively. The expression of transcription factors Nkx2-1, Pax8, and Foxe1 involved in thyroidogenesis were studied by quantitative RT-PCR at the same embryonic stages. We then compared the adult phenotype at 8 to 12 weeks in Dyrk1A(+/++) and WT mice for T4 and TSH levels, thyroidal weight, and histological analysis. Regarding thyroidal development, at E15.5, Dyrk1A(+/++) thyroid lobes are double the size of WT thyroids (P = .01), but the thyroglobulin stained surface in Dyrk1A(+/++) thyroids is less than a third as large at E17.5 (P = .04) and their differentiated follicular surface half the size (P = .004). We also observed a significant increase in Nkx2-1, Foxe1, and Pax8 RNA levels in E13.5 and E17.5 Dyrk1A(+/++) embryonic thyroids. Dyrk1A(+/++) young adult mice have significantly lower plasma T4 (2.4 ng/mL versus WT, 3.7 ng/mL; P = 0.019) and nonsignificantly higher plasma TSH (114 mUI/L versus WT, 73mUI/L; P = .09). In addition, their thyroids are significantly heavier (P = .04) and exhibit large disorganized regions. Dyrk1A overexpression directly leads to thyroidal embryogenetic, functional and morphological impairment. The young adult thyroid phenotype is probably a result of embryogenetic impairment. The Dyrk1A(+/++) mouse can be considered a suitable study model for thyroid dysgenesis in DS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25490145     DOI: 10.1210/en.2014-1329

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

Review 1.  Genetics of congenital hypothyroidism: Modern concepts.

Authors:  Athanasia Stoupa; Dulanjalee Kariyawasam; Michel Polak; Aurore Carré
Journal:  Pediatr Investig       Date:  2022-05-14

Review 2.  Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

Authors:  Paul van Trotsenburg; Athanasia Stoupa; Juliane Léger; Tilman Rohrer; Catherine Peters; Laura Fugazzola; Alessandra Cassio; Claudine Heinrichs; Veronique Beauloye; Joachim Pohlenz; Patrice Rodien; Regis Coutant; Gabor Szinnai; Philip Murray; Beate Bartés; Dominique Luton; Mariacarolina Salerno; Luisa de Sanctis; Mariacristina Vigone; Heiko Krude; Luca Persani; Michel Polak
Journal:  Thyroid       Date:  2021-03       Impact factor: 6.568

Review 3.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

4.  TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology.

Authors:  Athanasia Stoupa; Frédéric Adam; Dulanjalee Kariyawasam; Catherine Strassel; Sanjay Gawade; Gabor Szinnai; Alexandre Kauskot; Dominique Lasne; Carsten Janke; Kathiresan Natarajan; Alain Schmitt; Christine Bole-Feysot; Patrick Nitschke; Juliane Léger; Fabienne Jabot-Hanin; Frédéric Tores; Anita Michel; Arnold Munnich; Claude Besmond; Raphaël Scharfmann; François Lanza; Delphine Borgel; Michel Polak; Aurore Carré
Journal:  EMBO Mol Med       Date:  2018-12       Impact factor: 12.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.